CK Life Sciences Int'l., (Holdings) Inc.
HKEX:0775.HK
0.405 (HKD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q2 | 2011 Q4 | 2011 Q2 | 2010 Q4 | 2010 Q2 | 2009 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,635.851 | 2,743.605 | 2,579.128 | 2,735.008 | 2,540.582 | 2,763.924 | 2,638.388 | 2,563.014 | 2,379.53 | 2,370.51 | 2,596.514 | 2,691.782 | 2,541.21 | 2,379.176 | 2,313.957 | 2,340.873 | 2,527.667 | 2,470.046 | 2,449.263 | 2,537.251 | 2,416.792 | 2,489.752 | 2,481.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 1,836.417 | 2,252.079 | 2,122.947 | 2,201.613 | 2,086.124 | 2,286.467 | 2,171.727 | 2,247.276 | 1,936.155 | 1,679.032 | 1,781.16 | 1,808.605 | 1,690.023 | 1,625.217 | 1,524.105 | 1,571.957 | 1,634.085 | 1,591.305 | 1,586.157 | 1,625.469 | 1,588.252 | 1,611.454 | 1,617.659 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 799.434 | 491.526 | 456.181 | 533.395 | 454.458 | 477.457 | 466.661 | 315.738 | 443.375 | 691.478 | 815.354 | 883.177 | 851.187 | 753.959 | 789.852 | 768.916 | 893.582 | 878.741 | 863.106 | 911.782 | 828.54 | 878.298 | 863.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.303 | 0.179 | 0.177 | 0.195 | 0.179 | 0.173 | 0.177 | 0.123 | 0.186 | 0.292 | 0.314 | 0.328 | 0.335 | 0.317 | 0.341 | 0.328 | 0.354 | 0.356 | 0.352 | 0.359 | 0.343 | 0.353 | 0.348 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 72.904 | 74.943 | 70.931 | 99.766 | 58.769 | 59.558 | 97.711 | 100.088 | 49.685 | 81.976 | 40.308 | 120.09 | 31.745 | 120.915 | 53.368 | 87.572 | 82.903 | 88.887 | 94.238 | 109.327 | 81.496 | 122.325 | 103.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 318.099 | 316.599 | 261.386 | 325.447 | 263.95 | 350.441 | 199.796 | 333.91 | 190.677 | 599.779 | 505.32 | 263.595 | 261.147 | 247.853 | 259.466 | 258.77 | 262.903 | 247.544 | 244.175 | 253.712 | 244.274 | 247.045 | 242.918 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 391.003 | 391.542 | 332.317 | 425.213 | 322.719 | 409.999 | 297.507 | 433.998 | 240.362 | 681.755 | 545.628 | 611.719 | 583.53 | 582.626 | 544.286 | 593.663 | 613.383 | 785.583 | 605.244 | 710.164 | 607.117 | 703.129 | 640.594 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income
| 408.431 | 99.984 | 123.864 | 108.182 | 131.739 | 67.458 | 169.154 | -118.26 | 203.013 | 9.723 | 269.726 | 128.178 | 254.551 | -32.429 | 215.035 | 66.08 | 250.955 | 123.469 | 155.208 | 129.2 | 181.233 | 129.504 | 191.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income Ratio
| 0.155 | 0.036 | 0.048 | 0.04 | 0.052 | 0.024 | 0.064 | -0.046 | 0.085 | 0.004 | 0.104 | 0.048 | 0.1 | -0.014 | 0.093 | 0.028 | 0.099 | 0.05 | 0.063 | 0.051 | 0.075 | 0.052 | 0.077 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -403.437 | -88.501 | -67.096 | -8.958 | -26.123 | -374.557 | -30.726 | -280.369 | -77.015 | -0.439 | -62.426 | 115.521 | -39.565 | -257.38 | -22.454 | 43.447 | 277.318 | 338.784 | -318.524 | 441.508 | 310.269 | 374.972 | -12.803 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax
| 4.994 | 11.483 | 56.768 | 99.224 | 105.616 | 98.606 | 138.428 | -8.352 | 125.998 | 9.284 | 207.3 | 206.24 | 214.986 | 127.811 | 202.182 | 130.709 | 231.452 | 43.412 | 206.169 | 151.165 | 169.965 | 125.052 | 178.677 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| 0.002 | 0.004 | 0.022 | 0.036 | 0.042 | 0.036 | 0.052 | -0.003 | 0.053 | 0.004 | 0.08 | 0.077 | 0.085 | 0.054 | 0.087 | 0.056 | 0.092 | 0.018 | 0.084 | 0.06 | 0.07 | 0.05 | 0.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 3.993 | 31.396 | 19.938 | 31.922 | 40.99 | 36.937 | 38.501 | -45.611 | 39.509 | -3.779 | 31.253 | 82.015 | 38.522 | 20.317 | 29.131 | 54.97 | 39.976 | 36.666 | 26.787 | 33.266 | 15.112 | 38.217 | 30.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income
| 1.001 | -19.662 | 36.912 | 66.843 | 65.12 | 62.407 | 100.394 | 37.793 | 87.441 | 10.482 | 171.253 | 92.069 | 170.932 | 88.128 | 170.274 | 65.541 | 187.419 | 40.191 | 178.666 | 116.95 | 146.608 | 89.08 | 139.928 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income Ratio
| 0 | -0.007 | 0.014 | 0.024 | 0.026 | 0.023 | 0.038 | 0.015 | 0.037 | 0.004 | 0.066 | 0.034 | 0.067 | 0.037 | 0.074 | 0.028 | 0.074 | 0.016 | 0.073 | 0.046 | 0.061 | 0.036 | 0.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| 0 | -0.002 | 0.004 | 0.007 | 0.007 | 0.007 | 0.01 | 0.004 | 0.009 | 0.001 | 0.018 | 0.01 | 0.018 | 0.009 | 0.018 | 0.007 | 0.02 | 0.004 | 0.019 | 0.012 | 0.015 | 0.009 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS Diluted
| 0 | -0.002 | 0.004 | 0.007 | 0.007 | 0.007 | 0.01 | 0.004 | 0.009 | 0.001 | 0.018 | 0.01 | 0.018 | 0.009 | 0.018 | 0.007 | 0.02 | 0.004 | 0.019 | 0.012 | 0.015 | 0.009 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA
| 234.244 | 147.766 | 172.202 | 158.083 | 183.414 | 123.46 | 227.44 | 100.456 | 253.893 | 145.761 | 336.485 | 236.368 | 284.654 | 41.245 | 286.208 | 167.206 | 284.854 | 214.913 | 218.802 | 232.049 | 214.687 | 228.773 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA Ratio
| 0.089 | 0.054 | 0.067 | 0.058 | 0.072 | 0.045 | 0.086 | -0.024 | 0.107 | 0.026 | 0.122 | 0.088 | 0.112 | 0.017 | 0.124 | 0.071 | 0.113 | 0.087 | 0.089 | 0.091 | 0.089 | 0.092 | 0.092 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |